SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-069649
Filing Date
2008-11-10
Accepted
2008-11-10 15:05:40
Documents
6
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a08-25359_110q.htm 10-Q 595844
2 EX-10.65 a08-25359_1ex10d65.htm EX-10.65 109842
3 EX-10.66 a08-25359_1ex10d66.htm EX-10.66 28160
4 EX-31.1 a08-25359_1ex31d1.htm EX-31.1 11700
5 EX-31.2 a08-25359_1ex31d2.htm EX-31.2 11745
6 EX-32 a08-25359_1ex32.htm EX-32 10955
  Complete submission text file 0001104659-08-069649.txt   769754
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 081175083
SIC: 2834 Pharmaceutical Preparations